Worldquant Millennium Advisors LLC Biomarin Pharmaceutical Inc Transaction History

Worldquant Millennium Advisors LLC

$19.2 Billion
Q2 2025

A detailed history of Worldquant Millennium Advisors LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 501,148 shares of BMRN stock, worth $26.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

501,148

Previous 238,134 110.45%

Holding current value

$26.3 Million

Previous $16.8 Million 63.65%

% of portfolio

0.14%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$54.08 - $68.32 $14.2 Million - $18 Million	263,014 Added 110.45%	501,148 $27.5 Million
Q1 2025 May 15, 2025	SELL	$61.25 - $72.83 $2.45 Million - $2.91 Million	-39,984 Reduced 14.38%	238,134 $16.8 Million
Q4 2024 Feb 14, 2025	BUY	$61.93 - $70.49 $13.3 Million - $15.1 Million	214,546 Added 337.49%	278,118 $18.3 Million
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $4.39 Million - $5.97 Million	63,572 New	63,572 $4.47 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $12.5 Million - $16.8 Million	-154,461 Reduced 87.1%	22,872 $2.37 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $7.58 Million - $8.95 Million	92,275 Added 108.48%	177,333 $15 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $4.31 Million - $5.23 Million	60,231 Added 242.6%	85,058 $7.05 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $2.6 Million - $3.25 Million	-35,024 Reduced 58.52%	24,827 $1.91 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $1.66 Million - $2.12 Million	-23,150 Reduced 27.89%	59,851 $5.29 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $6.21 Million - $7.09 Million	83,001 New	83,001 $6.42 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $2.38 Million - $2.95 Million	-32,717 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $4.23 Million - $7.72 Million	-58,915 Reduced 64.3%	32,717 $2.49 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $938,928 - $1.47 Million	-11,803 Reduced 11.41%	91,632 $11.3 Million
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $196,909 - $267,209	2,759 Added 2.74%	103,435 $8.74 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $1.27 Million - $1.71 Million	-19,771 Reduced 16.41%	100,676 $8.51 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $785,749 - $992,212	-11,658 Reduced 8.82%	120,447 $8.12 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.56 Million - $1.82 Million	19,398 Added 17.21%	132,105 $11.3 Million
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $2.87 Million - $3.36 Million	-34,064 Reduced 23.21%	112,707 $10 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $2.61 Million - $3.45 Million	-32,523 Reduced 18.14%	146,771 $12.5 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $3.71 Million - $4.18 Million	39,532 Added 28.29%	179,294 $17.4 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $10.6 Million - $13.8 Million	139,762 New	139,762 $13.2 Million

Others Institutions Holding BMRN

# of Institutions

679

Shares Held

185M

Call Options Held

1.31M

Put Options Held

1.1M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $9.75B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.

Account

Worldquant Millennium Advisors LLC Biomarin Pharmaceutical Inc Transaction History